Exopharm

Peter van Bruchem Hardware & devices, Health & biotech
Company Owned Profile: No


Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Exopharm (ASX:EX1) is a leader in exosome technology and holds a portfolio of intellectual property and know-how related to exosomes and the manufacture of exosomes.
Exosomes could be an alternative means of drug-delivery inside the body, alongside technologies such as lipid nanoparticles (LNP), cell-penetrating peptides, viral vectors and liposomes.
Exopharm's exosome technologies solve important needs for the success of exosome medicines ‚ LEAP manufacturing technology, LOAD API loading technologies and EVPS tropism technologies.
Exosome-based medicines could improve the treatment of many chronic or inherited medical conditions.
Exopharm is making its proprietary technologies available to pharmaceutical and biotechnology companies that want to harness exosome-delivery for their own products.
Category: Hardware & devices, Health & biotech
URL: http://exopharm.com
Operational Status:
ASX Listing Code (if applicable):
Year of Commencement: 2013
Address:

Melbourne, Melbourne, AU
State: Victoria
Overseas Operations:
X:
Facebook:
Linkedin: https://linkedin.com/company/exopharm
Founders:
No items found
Awards won: